\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ exam\\ \\&\\ labs\ \(0\)\
\-\ semi\\-annual\\ monitoring\\ ct\\ scan\\ to\\ evaluate\\ for\\ progression\\ of\\ disease\\.\\ \\ if\\ plaques\\ remain\\ stable\\,\\ will\\ conduct\\ annual\\ follow\\-up\\ evaluations\\.\ \(0\)\
\-\ \\â\\€\\¢\\ lung\\ parenchyma\\ \\-\\ no\\ masses\\ or\\ airspace\\ disease\\.\ \(0\)\
\-\ \\â\\€\\¢\\ bilaterally\\,\\ numerous\\ calcified\\ pleural\\ plaques\\ along\\ thoracic\\ cage\\ and\\ diaphragmatic\\ surfaces\\.\ \(0\)\
\-\ \\â\\€\\¢\\ small\\ rectangular\\ scattered\\ non\\-calcified\\ pleural\\ thickenings\\ are\\ also\\ observed\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ there\\ is\\ no\\ mediastinal\\,\\ hilar\\ or\\ axillary\\ lymphadenopathy\\.\ \(0\)\
\-\ pleural\\ plaques\\ consistent\\ with\\ asbestos\\ exposure\ \(0\)\
\-\ \\â\\€\\¢\\ asbestos\\ exposure\ \(0\)\
\-\ \\â\\€\\¢\\ pleural\\ tb\ \(0\)\
\-\ \\â\\€\\¢\\ pleural\\ metastasis\ \(0\)\
\-\ 56\\ y\\.o\\.\\ man\\ presents\\ for\\ follow\\ up\\ after\\ initial\\ evaluation\\ of\\ rib\\ pain\\ from\\ a\\ bicycle\\ tumble\\.\ \(1\)\
\-\ denies\\ any\\ pulmonary\\ symptoms\ \(0\)\
\-\ pleural\\ plaques\\ are\\ circumscribed\\ areas\\ of\\ pleural\\ thickening\\,\\ often\\ diffuse\\ or\\ multifocal\\.\\ these\\ may\\ frequently\\ be\\ calcified\\,\\ and\\ are\\ characteristically\\ found\\ along\\ the\\ lower\\ thorax\\ and\\ diaphragmatic\\ pleura\\.\\ the\\ lesions\\ are\\ only\\ rarely\\ found\\ in\\ the\\ costophrenic\\ sulci\\ and\\ lung\\ apices\\ most\\ often\\ avoiding\\ these\\ areas\\.\\ calcified\\ diaphragmatic\\ pleural\\ plaques\\ are\\ essentially\\ pathognomonic\\ for\\ asbestos\\ exposure\\,\\ and\\ may\\ develop\\ as\\ much\\ as\\ 20\\ years\\ after\\ initial\\ exposure\\.\\ \ \(0\)\
\-\ asbestosis\\ is\\ a\\ pneumoconiosis\\ resulting\\ from\\ the\\ inhalation\\ of\\ asbestos\\ fibers\\ and\\ leads\\ to\\ a\\ slowly\\ progressive\\ diffuse\\ pulmonary\\ fibrosis\\.\\ the\\ primary\\ complications\\ are\\ respiratory\\ failure\\ and\\ malignancy\\ \\(asbestos\\ expsore\\ may\\ increase\\ the\\ risk\\ of\\ malignant\\ mesothelioma\\ by\\ 300\\ fold\\ compared\\ to\\ non\\-exposed\\ individuals\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ asbestos\\:\\ 0\\.12241431482839114\ \(0\)\
\-\ pleural\\:\\ 0\\.11442586891976883\ \(0\)\
\-\ plaques\\:\\ 0\\.10285489560629199\ \(0\)\
\-\ exposure\\:\\ 0\\.07665638916378409\ \(0\)\
\-\ diaphragmatic\\:\\ 0\\.06315119988675222\ \(0\)\
\-\ calcified\\:\\ 0\\.047431344144220414\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.047280605436082826\ \(0\)\
\-\ semi\\-annual\\:\\ 0\\.03799792424123491\ \(0\)\
\-\ thickenings\\:\\ 0\\.03799792424123491\ \(0\)\
\-\ tumble\\:\\ 0\\.03799792424123491\ \(0\)\
\-\ expsore\\:\\ 0\\.03799792424123491\ \(0\)\
\-\ non\\-exposed\\:\\ 0\\.03799792424123491\ \(0\)\
\-\ conduct\\:\\ 0\\.03501022087675238\ \(0\)\
\-\ rectangular\\:\\ 0\\.03501022087675238\ \(0\)\
\-\ are\\:\\ 0\\.0301260484274897\ \(0\)\
\-\ avoiding\\:\\ 0\\.029610380495306832\ \(0\)\
\-\ bicycle\\:\\ 0\\.02852712864926844\ \(0\)\
\-\ inhalation\\:\\ 0\\.02852712864926844\ \(0\)\
\-\ evaluations\\:\\ 0\\.027662168755035032\ \(0\)\
\-\ non\\-calcified\\:\\ 0\\.027662168755035032\ \(0\)\
\-\ apices\\:\\ 0\\.027287119716286626\ \(0\)\
\-\ cage\\:\\ 0\\.026942108045280005\ \(0\)\
\-\ 300\\:\\ 0\\.026622677130824307\ \(0\)\
\-\ asbestosis\\:\\ 0\\.026325294064070207\ \(0\)\
\-\ pneumoconiosis\\:\\ 0\\.025785797758233975\ \(0\)\
\-\ characteristically\\:\\ 0\\.02530637691724163\ \(0\)\
\-\ areas\\:\\ 0\\.02478747561419023\ \(0\)\
\-\ fold\\:\\ 0\\.024482862965678226\ \(0\)\
\-\ initial\\:\\ 0\\.024410190890338863\ \(0\)\
\-\ along\\:\\ 0\\.02434529204188376\ \(0\)\
\-\ may\\:\\ 0\\.02423700477023436\ \(0\)\
\-\ costophrenic\\:\\ 0\\.02412345947887197\ \(0\)\
\-\ surfaces\\:\\ 0\\.023954404680797483\ \(0\)\
\-\ often\\:\\ 0\\.02350408231482459\ \(0\)\
\-\ found\\:\\ 0\\.023215738055621656\ \(0\)\
\-\ mesothelioma\\:\\ 0\\.02305940741882229\ \(0\)\
\-\ diffuse\\:\\ 0\\.022301788106683748\ \(0\)\
\-\ airspace\\:\\ 0\\.022206710249296775\ \(0\)\
\-\ pleura\\:\\ 0\\.022206710249296775\ \(0\)\
\-\ pulmonary\\:\\ 0\\.02152198543293158\ \(0\)\
\-\ individuals\\:\\ 0\\.021495159601195704\ \(0\)\
\-\ lung\\:\\ 0\\.02133757862274781\ \(0\)\
\-\ sulci\\:\\ 0\\.021050399962250742\ \(0\)\
\-\ thorax\\:\\ 0\\.020884597027648177\ \(0\)\
\-\ fibers\\:\\ 0\\.020724936373853566\ \(0\)\
\-\ remain\\:\\ 0\\.02064727040185926\ \(0\)\
\-\ essentially\\:\\ 0\\.02064727040185926\ \(0\)\
\-\ leads\\:\\ 0\\.020570979121258395\ \(0\)\
\-\ monitoring\\:\\ 0\\.020349887335105163\ \(0\)\
\-\ axillary\\:\\ 0\\.02000487566409854\ \(0\)\
\-\ slowly\\:\\ 0\\.02000487566409854\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.019939067594569277\ \(0\)\
\-\ multifocal\\:\\ 0\\.019810391029268928\ \(0\)\
\-\ 56\\:\\ 0\\.019388061682888744\ \(0\)\
\-\ these\\:\\ 0\\.019171074930671037\ \(0\)\
\-\ hilar\\:\\ 0\\.01850745623671318\ \(0\)\
\-\ annual\\:\\ 0\\.018460857460401905\ \(0\)\
\-\ rib\\:\\ 0\\.018414757076277995\ \(0\)\
\-\ develop\\:\\ 0\\.018369144536060162\ \(0\)\
\-\ progression\\:\\ 0\\.01832400962283906\ \(0\)\
\-\ tb\\:\\ 0\\.01773723300937104\ \(0\)\
\-\ observed\\:\\ 0\\.017659567037376738\ \(0\)\
\-\ rarely\\:\\ 0\\.017659567037376738\ \(0\)\
\-\ scattered\\:\\ 0\\.017151881538857845\ \(0\)\
\-\ much\\:\\ 0\\.017050456981055284\ \(0\)\
\-\ numerous\\:\\ 0\\.01651686121663001\ \(0\)\
\-\ fibrosis\\:\\ 0\\.01640035831840622\ \(0\)\
\-\ circumscribed\\:\\ 0\\.016371718048067127\ \(0\)\
\-\ resulting\\:\\ 0\\.016176393926463497\ \(0\)\
\-\ frequently\\:\\ 0\\.015963494119008426\ \(0\)\
\-\ parenchyma\\:\\ 0\\.015686934014623573\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.015662650317562126\ \(0\)\
\-\ mediastinal\\:\\ 0\\.0156385026643351\ \(0\)\
\-\ compared\\:\\ 0\\.015590609451296002\ \(0\)\
\-\ denies\\:\\ 0\\.01554324254795292\ \(0\)\
\-\ increase\\:\\ 0\\.0154500422720341\ \(0\)\
\-\ respiratory\\:\\ 0\\.015291639072858491\ \(0\)\
\-\ after\\:\\ 0\\.015241389677665538\ \(0\)\
\-\ stable\\:\\ 0\\.015181955169146577\ \(0\)\
\-\ evaluate\\:\\ 0\\.01488890628559083\ \(0\)\
\-\ complications\\:\\ 0\\.01459557239229335\ \(0\)\
\-\ progressive\\:\\ 0\\.014557927220014236\ \(0\)\
\-\ failure\\:\\ 0\\.014428699494962787\ \(0\)\
\-\ malignancy\\:\\ 0\\.014233145162937569\ \(0\)\
\-\ thoracic\\:\\ 0\\.014198523733207982\ \(0\)\
\-\ metastasis\\:\\ 0\\.013787703992672097\ \(0\)\
\-\ risk\\:\\ 0\\.013341407962754683\ \(0\)\
\-\ malignant\\:\\ 0\\.01331323567404871\ \(0\)\
\-\ 20\\:\\ 0\\.013243600155849206\ \(0\)\
\-\ or\\:\\ 0\\.012950725202116908\ \(0\)\
\-\ \\&\\:\\ 0\\.012937016776471688\ \(0\)\
\-\ labs\\:\\ 0\\.012810232788513527\ \(0\)\
\-\ thickening\\:\\ 0\\.012485450731436861\ \(0\)\
\-\ masses\\:\\ 0\\.012450829301707272\ \(0\)\
\-\ bilaterally\\:\\ 0\\.012097867407430617\ \(0\)\
\-\ disease\\:\\ 0\\.012040840872549174\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.011982918066559232\ \(0\)\
\-\ follow\\:\\ 0\\.011703445999769113\ \(0\)\
\-\ any\\:\\ 0\\.01159842686669092\ \(0\)\
\-\ will\\:\\ 0\\.01152362507922044\ \(0\)\
\-\ as\\:\\ 0\\.011142909533570068\ \(0\)\
\-\ only\\:\\ 0\\.011075050252090239\ \(0\)\
\-\ from\\:\\ 0\\.010917549251329416\ \(0\)\
\-\ primary\\:\\ 0\\.010911139064205587\ \(0\)\
\-\ years\\:\\ 0\\.010815703176803804\ \(0\)\
\-\ evaluation\\:\\ 0\\.010699305154425895\ \(0\)\
\-\ y\\.o\\:\\ 0\\.010630945830115087\ \(0\)\
\-\ scan\\:\\ 0\\.01031151491565939\ \(0\)\
\-\ if\\:\\ 0\\.009994583766295842\ \(0\)\
\-\ up\\:\\ 0\\.009904513582130273\ \(0\)\
\-\ lesions\\:\\ 0\\.009860174596310119\ \(0\)\
\-\ for\\:\\ 0\\.009428122611759246\ \(0\)\
\-\ symptoms\\:\\ 0\\.009179558090078185\ \(0\)\
\-\ consistent\\:\\ 0\\.009031458055306911\ \(0\)\
\-\ man\\:\\ 0\\.008710913116767237\ \(0\)\
\-\ most\\:\\ 0\\.008503599748827913\ \(0\)\
\-\ small\\:\\ 0\\.0084852382947462\ \(0\)\
\-\ lower\\:\\ 0\\.00828388823001665\ \(0\)\
\-\ exam\\:\\ 0\\.008091525603230768\ \(0\)\
\-\ \\-\\:\\ 0\\.00789538128753605\ \(0\)\
\-\ presents\\:\\ 0\\.007524328859947956\ \(0\)\
\-\ no\\:\\ 0\\.007417621988825879\ \(0\)\
\-\ also\\:\\ 0\\.007261291352026514\ \(0\)\
\-\ \\,\\:\\ 0\\.007001122384067777\ \(0\)\
\-\ by\\:\\ 0\\.00613306423812446\ \(0\)\
\-\ normal\\:\\ 0\\.0057741916146512974\ \(0\)\
\-\ be\\:\\ 0\\.005679985876482453\ \(0\)\
\-\ to\\:\\ 0\\.005522432436762753\ \(0\)\
\-\ there\\:\\ 0\\.005481532570969778\ \(0\)\
\-\ and\\:\\ 0\\.0054313062074376256\ \(0\)\
\-\ ct\\:\\ 0\\.005152170919793289\ \(0\)\
\-\ a\\:\\ 0\\.005128445713171568\ \(0\)\
\-\ is\\:\\ 0\\.004847334296420048\ \(0\)\
\-\ pain\\:\\ 0\\.004498311066942822\ \(0\)\
\-\ the\\:\\ 0\\.003575412535438598\ \(0\)\
\-\ \\(\\:\\ 0\\.003113628130361468\ \(0\)\
\-\ \\)\\:\\ 0\\.003075593500488384\ \(0\)\
\-\ of\\:\\ 0\\.002510857775818716\ \(0\)\
\-\ \\.\\:\\ 0\\.0021422133851846893\ \(0\)\
\-\ in\\:\\ 0\\.0018163673712942024\ \(0\)\
\-\ with\\:\\ 0\\.000504328345215042\ \(0\)\
